Coach vs. Kors: Bat...
Health Care: Drugs
Athersys Inc. (ATHX: OTC)
$1.41 -0.07 | -4.73%
06/01/12 - 03:59 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 8.78M | 2.10M | 11.17M | 12.55M |
| Receivables | 689.00K | 2.50M | 674.00K | 683.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 14.41M | 17.94M | 22.15M | 29.10M |
| Property, Plant & Equipment, Gross | 10.24M | 9.65M | 9.90M | 9.65M |
| Accumulated Depreciation & Depletion | 8.97M | 8.69M | 9.05M | 8.95M |
| Property, Plant & Equipment, Net | 1.27M | 955.00K | 849.00K | 701.00K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 28.00K | 207.00K | 5.33M | 4.07M |
| Total Non-Current Assets | 1.30M | 1.16M | 6.18M | 4.77M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 15.70M | 19.11M | 28.33M | 33.88M |
| Accounts Payable | 2.30M | 1.50M | 1.13M | 1.50M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 3.12M | 0.00 |
| Total Current Liabilities | 7.42M | 8.84M | 5.86M | 2.31M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 983.00K | 1.26M | 3.52M | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 983.00K | 1.26M | 3.52M | 0.00 |
| Total Liabilities | 8.40M | 10.10M | 9.37M | 2.31M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 7.30M | 9.00M | 18.96M | 31.56M |
| Common Par | 24.00K | 19.00K | 19.00K | 19.00K |
| Additional Paid In Capital | 226.21M | 214.17M | 212.70M | 209.90M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -218.96M | -205.21M | -193.84M | -178.47M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 28.00K | 26.00K | 71.00K | 120.00K |
| Total Capitalization | 7.30M | 9.00M | 18.96M | 31.56M |
| Total Equity | 7.30M | 9.00M | 18.96M | 31.56M |
| Total Liabilities & Stock Equity | 15.70M | 19.11M | 28.33M | 33.88M |
| Total Common Shares Outstanding | 24.49M | 18.93M | 18.93M | 18.93M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 23.24M | 18.93M | 18.93M | 18.93M |
| Diluted Weighted Shares Outstanding | 23.24M | 18.93M | 18.93M | 18.93M |
| Number of Employees | 48 | 44 | 37 | 35 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ATHX
- Portfolio NameUser Type
- Contributor10 Cheap Biotech Stocks Tha...
- UserAlfa
- Contributor9 Health Care Stocks With 1...
- Contributor10 Pharma Stocks With 100% ...
- Contributor10 Biotech Stocks Expected ...
- UserFuture Speculation
- User©SUPRATRADE HOT STOCKS (...
- UserBesV Portfolio 1
- Userdawnf Portfolio 1
- UserMangar's picks
Latest ATHX Headlines from TheStreet
- Aastrom Raises Cash To Fund Pivotal Trial 03.09.12 | 12:03 pm
- Athersys Reports Fourth Quarter And 2010 Annual Results 03.14.11 | 04:03 pm
- Athersys Announces Initiation Of Patient Enrollment For Phase II Clinical Trial In Inflammatory Bowel Disease 03.14.11 | 07:03 am
- Athersys To Host Fourth Quarter Financial Results Call 02.18.11 | 07:02 am
- Researchers From UTHealth And Athersys Present Preclinical Data Illustrating Potential Benefits Of MultiStem(R) For Treating Stroke 02.10.11 | 07:02 am
- Athersys To Present At 13th Annual BIO CEO & Investor Conference 02.08.11 | 02:02 pm
- 10 Pharma Stocks With 100% Buy Ratings 02.03.11 | 11:02 am
- Athersys Announces Registered Direct Offering Of $13.1 Million 01.28.11 | 09:01 am
- Researchers From Case Western Reserve And Athersys Publish Landmark Study Showing Regenerative Benefit Of MultiStem Therapy After Spinal Cord Injury 01.19.11 | 07:01 am
- Athersys Announces Completion Of Patient Enrollment For Single Dose Arm Of Phase I Study Of MultiStem(R) For Hematopoietic Stem Cell Transplant Support 01.06.11 | 07:01 am
Press Releases for ATHX
- Athersys, Inc. - Retail Investor Conferences.com Presentation Now Available Online - PR Newswire 01.24.11 | 12:01 pm
- RTI Biologics And Athersys Announce Collaboration In The Orthopedic Market - Business Wire 09.13.10 | 07:09 am
Partner Headlines for ATHX
- Follow the Analyst Leader: New Stock Coverage to Watch - Wall St. Cheat Sheet 05.31.12 | 04:05 am
- Microcap Movers for Friday December 2 , 2011 - Benzinga 12.02.11 | 05:12 pm
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 09.29.11 | 09:09 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 09.23.11 | 09:09 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.31.11 | 09:08 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 08.26.11 | 09:08 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 08.12.11 | 09:08 am
- Athersys Q2 Loss Is Slight Improvement Over Previous Year - Seeking Alpha 08.11.11 | 09:08 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 05.10.11 | 09:05 am
- 4 Biotech Companies That Could Be Buyout Targets - Seeking Alpha 04.05.11 | 08:04 am
